Literature DB >> 31815559

The importance of targeting HIV reservoirs: preclinical insights on current and potential therapeutic opportunities.

Theodore J Cory1.   

Abstract

Entities:  

Keywords:  HIV-1; block and lock; shock and kill; tissue reservoir; viral reservoir

Year:  2019        PMID： 31815559      PMCID： PMC6943822          DOI： 10.1080/14728222.2019.1702971

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  10 in total

Review 1.  HIV "shock and kill" therapy: In need of revision.

Authors:  Erik Abner; Albert Jordan
Journal:  Antiviral Res       Date:  2019-03-23       Impact factor: 5.970

2.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.

Authors:  Courtney V Fletcher; Kathryn Staskus; Stephen W Wietgrefe; Meghan Rothenberger; Cavan Reilly; Jeffrey G Chipman; Greg J Beilman; Alexander Khoruts; Ann Thorkelson; Thomas E Schmidt; Jodi Anderson; Katherine Perkey; Mario Stevenson; Alan S Perelson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

3.  In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.

Authors:  Cari F Kessing; Christopher C Nixon; Chuan Li; Perry Tsai; Hiroshi Takata; Guillaume Mousseau; Phong T Ho; Jenna B Honeycutt; Mohammad Fallahi; Lydie Trautmann; J Victor Garcia; Susana T Valente
Journal:  Cell Rep       Date:  2017-10-17       Impact factor: 9.423

4.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

5.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

6.  Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy.

Authors:  Jacob D Estes; Cavan Reilly; Charles M Trubey; Courtney V Fletcher; Theodore J Cory; Michael Piatak; Samuel Russ; Jodi Anderson; Thomas G Reimann; Robert Star; Anthony Smith; Russell P Tracy; Anna Berglund; Thomas Schmidt; Vicky Coalter; Elena Chertova; Jeremy Smedley; Ashley T Haase; Jeffrey D Lifson; Timothy W Schacker
Journal:  J Infect Dis       Date:  2014-09-22       Impact factor: 5.226

7.  HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.

Authors:  Ian H Gabriel; Eduardo Olavarria; Ravindra K Gupta; Sultan Abdul-Jawad; Laura E McCoy; Hoi Ping Mok; Dimitra Peppa; Maria Salgado; Javier Martinez-Picado; Monique Nijhuis; Annemarie M J Wensing; Helen Lee; Paul Grant; Eleni Nastouli; Jonathan Lambert; Matthew Pace; Fanny Salasc; Christopher Monit; Andrew J Innes; Luke Muir; Laura Waters; John Frater; Andrew M L Lever; Simon G Edwards
Journal:  Nature       Date:  2019-03-05       Impact factor: 49.962

8.  Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues.

Authors:  Meghan Rothenberger; Krystelle Nganou-Makamdop; Cissy Kityo; Francis Ssali; Jeffrey G Chipman; Gregory J Beilman; Torfi Hoskuldsson; Jodi Anderson; Jake Jasurda; Thomas E Schmidt; Samuel P Calisto; Hope Pearson; Thomas Reimann; Caitlin David; Katherine Perkey; Peter Southern; Steve Wietgrefe; Erika Helgeson; Cavan Reilly; Ashley T Haase; Daniel C Douek; Courtney V Fletcher; Timothy W Schacker
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

9.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

10.  Persistent HIV-1 replication maintains the tissue reservoir during therapy.

Authors:  Ramon Lorenzo-Redondo; Helen R Fryer; Trevor Bedford; Eun-Young Kim; John Archer; Sergei L Kosakovsky Pond; Yoon-Seok Chung; Sudhir Penugonda; Jeffrey Chipman; Courtney V Fletcher; Timothy W Schacker; Michael H Malim; Andrew Rambaut; Ashley T Haase; Angela R McLean; Steven M Wolinsky
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.